- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Wockhardt Limited — Updates, 31-12-2025: Press Release
31-12-2025 | 12:34 pm
31-12-2025 | 12:34 pm
Wockhardt's WCK 5222 (Zaynich®) received accelerated EMA assessment for multi-drug-resistant infections, reflecting its potential as a critical therapeutic option. This speeds up market entry for the India-discovered drug, a major pipeline milestone.
No comments yet. Be the first to comment!